Has the recent large observational data suggesting that continuing metformin during hospitalization is associated with lower post-discharge mortality and hypoglycemia changed your approach to holding it on admission in stable, non-critically ill patients with T2DM?
Gallo et al., PMID 39900873
Community PollStarted
Has recent observational data linking continued metformin use during hospitalization to lower post-discharge mortality and reduced hypoglycemia changed your approach in stable, non-critically ill patients with type 2 diabetes?
25 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Hospital Medicine · VA Boston Healthcare System
Answered on
I really like this paper, but I don't think it is plausible that a 5-day difference in receipt of metformin (the median length of stay was 5 days) could really affect 90-day mortality.
The study question is a good one because the evidence that metformin causes lactic acidosis is extremely limited. In...
Join for free or sign in to see the full answer